UTAH MEDICAL PRODUCTS, INC. (UTMD) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $32.00K; Additional Paid in Capital, Common StockUSD $0.00; Retained Earnings (Accumulated Deficit)USD $131.95M; Stockholders' Equity Attributable to ParentUSD $122.03M.
- 2026-03-31: Common Stock, Value, IssuedUSD $32.00K; Additional Paid in Capital, Common StockUSD $0.00; Retained Earnings (Accumulated Deficit)USD $130.26M; Stockholders' Equity Attributable to ParentUSD $120.37M.
- 2025-12-31: Common Stock, Value, IssuedUSD $32.00K; Additional Paid in Capital, Common StockUSD $0.00; Retained Earnings (Accumulated Deficit)USD $128.65M; Stockholders' Equity Attributable to ParentUSD $119.27M.
- 2025-09-30: Common Stock, Value, IssuedUSD $32.00K; Additional Paid in Capital, Common StockUSD $0.00; Retained Earnings (Accumulated Deficit)USD $127.96M; Stockholders' Equity Attributable to ParentUSD $118.25M.
UTAH MEDICAL PRODUCTS, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | AOCI Including Portion Attributable to Noncontrolling Interest, before Tax USD | Preferred Stock, Value, Issued USD | Accumulated Other Comprehensive Income (Loss), before Tax (Deprecated 2009-01-31) USD | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $32.00K | $0.00 | $131.95M | $122.03M | $122.03M | $-9.95M | (m) | (m) | (m) |
| 2026-03-31 | $32.00K | $0.00 | $130.26M | $120.37M | $120.37M | $-9.92M | (m) | (m) | (m) |
| 2025-12-31 | $32.00K | $0.00 | $128.65M | $119.27M | $119.27M | $-9.42M | (m) | (m) | (m) |
| 2025-09-30 | $32.00K | $0.00 | $127.96M | $118.25M | $118.25M | $-9.74M | (m) | (m) | (m) |
| 2025-06-30 | $32.00K | $0.00 | $126.86M | $117.53M | $117.53M | $-9.36M | (m) | (m) | (m) |
| 2025-03-31 | $33.00K | $0.00 | $128.20M | $117.05M | $117.05M | $-11.19M | (m) | (m) | (m) |
| 2024-12-31 | $33.00K | $0.00 | $129.30M | $117.43M | $117.43M | $-11.91M | (m) | (m) | (m) |
| 2024-09-30 | $34.00K | $0.00 | $134.05M | $124.20M | $124.20M | $-9.89M | (m) | (m) | (m) |
| 2024-06-30 | $35.00K | $0.00 | $135.34M | $124.05M | $124.05M | $-11.32M | (m) | (m) | (m) |
| 2024-03-31 | $36.00K | $0.00 | $139.00M | $127.74M | $127.74M | $-11.29M | (m) | (m) | (m) |
| 2023-12-31 | $36.00K | $594.00K | $138.34M | $128.31M | $128.31M | $-10.66M | (m) | (m) | (m) |
| 2023-09-30 | $36.00K | $521.00K | $135.14M | $123.70M | $123.70M | $-12.00M | (m) | (m) | (m) |
| 2023-06-30 | $36.00K | $432.00K | $132.28M | $121.76M | $121.76M | $-10.99M | (m) | (m) | (m) |
| 2023-03-31 | $36.00K | $322.00K | $129.15M | $118.02M | $118.02M | $-11.49M | (m) | (m) | (m) |
| 2022-12-31 | $36.00K | $251.00K | $126.01M | $114.25M | $114.25M | $-12.04M | (m) | (m) | (m) |
| 2022-09-30 | $36.00K | $58.00K | $122.52M | $108.19M | $108.19M | $-14.43M | (m) | (m) | (m) |
| 2022-06-30 | $36.00K | $0.00 | $119.29M | $107.47M | $107.47M | $-11.86M | (m) | (m) | (m) |
| 2022-03-31 | $37.00K | $903.00K | $117.79M | $109.17M | $109.17M | $-9.56M | (m) | (m) | (m) |
| 2021-12-31 | $37.00K | $841.00K | $115.31M | $107.14M | $107.14M | $-9.05M | (m) | (m) | (m) |
| 2021-09-30 | $36.00K | $520.00K | $118.49M | $109.98M | $109.98M | $-9.07M | (m) | (m) | (m) |
| 2021-06-30 | $36.00K | $289.00K | $115.33M | $107.36M | $107.36M | $-8.29M | (m) | (m) | (m) |
| 2021-03-31 | $36.00K | $245.00K | $112.94M | $104.88M | $104.88M | $-8.34M | (m) | (m) | (m) |
| 2020-12-31 | $36.00K | $115.00K | $110.95M | $102.82M | $102.82M | $-8.28M | (m) | (m) | (m) |
| 2020-09-30 | $36.00K | $0.00 | $108.58M | $98.42M | $98.42M | $-10.20M | $0.00 | (m) | (m) |
| 2020-06-30 | $36.00K | $80.00K | $106.88M | $95.29M | $95.29M | $-11.71M | $0.00 | (m) | (m) |
| 2020-03-31 | $36.00K | $0.00 | $106.58M | $94.39M | $94.39M | $-12.23M | $0.00 | (m) | (m) |
| 2019-12-31 | $37.00K | $18.00K | $110.82M | $101.09M | $101.09M | $-9.78M | $0.00 | (m) | (m) |
| 2019-09-30 | $37.00K | $0.00 | $107.44M | $94.99M | $94.99M | $-12.49M | $0.00 | (m) | (m) |
| 2019-06-30 | $37.00K | $0.00 | $104.68M | $93.91M | $93.91M | $-10.81M | $0.00 | (m) | (m) |
| 2019-03-31 | $37.00K | $246.00K | $102.23M | $92.17M | $92.17M | $-10.34M | $0.00 | (m) | (m) |
| 2018-12-31 | $37.00K | $122.00K | $100.12M | $88.99M | $88.99M | $-11.29M | $0.00 | (m) | (m) |
| 2018-09-30 | $37.00K | $1.30M | $97.76M | $88.83M | $88.83M | $-10.26M | $0.00 | (m) | (m) |
| 2018-06-30 | $37.00K | $1.20M | $92.00M | $83.36M | $83.36M | $-9.88M | (m) | (m) | (m) |
| 2018-03-31 | $37.00K | $986.00K | $88.70M | $82.69M | $82.69M | $-7.04M | (m) | (m) | (m) |
| 2017-12-31 | $37.00K | $809.00K | $85.62M | $78.12M | $78.12M | $-8.34M | $0.00 | (m) | (m) |
| 2017-09-30 | $37.00K | $701.00K | $89.14M | $81.20M | (m) | $-8.69M | (m) | (m) | (m) |
| 2017-06-30 | $37.00K | $615.00K | $86.51M | $77.25M | (m) | $-9.91M | (m) | (m) | (m) |
| 2017-03-31 | $37.00K | $467.00K | $83.62M | $72.54M | (m) | $-11.59M | (m) | (m) | (m) |
| 2016-12-31 | $37.00K | $378.00K | $81.07M | $69.24M | $69.24M | $-12.24M | (m) | (m) | 12 month · $50.00K |
| 2016-09-30 | $38.00K | $3.11M | $79.34M | $72.67M | (m) | $-9.82M | (m) | (m) | (m) |
| 2016-06-30 | $38.00K | $3.04M | $77.38M | $71.07M | (m) | $-9.39M | (m) | (m) | (m) |
| 2016-03-31 | $38.00K | $2.90M | $75.10M | $71.66M | (m) | $-6.38M | (m) | (m) | (m) |
| 2015-12-31 | $38.00K | $2.71M | $72.86M | $69.65M | $69.65M | $-5.96M | (m) | (m) | 12 month · $114.00K |
| 2015-09-30 | $37.00K | $2.64M | $70.62M | $68.35M | (m) | $-4.95M | (m) | (m) | (m) |
| 2015-06-30 | $38.00K | $3.03M | $68.53M | $68.19M | (m) | $-3.41M | (m) | (m) | (m) |
| 2015-03-31 | $38.00K | $3.00M | $66.57M | $63.84M | (m) | $-5.77M | (m) | (m) | (m) |
| 2014-12-31 | $37.00K | $2.89M | $64.86M | $64.56M | (m) | $-3.23M | (m) | (m) | 12 month · $103.00K |
| 2014-09-30 | $37.00K | $2.81M | $62.82M | $64.22M | (m) | $-1.44M | (m) | (m) | (m) |
| 2014-06-30 | $37.00K | $2.88M | $60.93M | $64.97M | (m) | $1.12M | (m) | (m) | (m) |
| 2014-03-31 | $38.00K | $3.60M | $59.03M | $62.94M | (m) | $264.00K | (m) | (m) | (m) |
| 2013-12-31 | $37.00K | $3.28M | $57.25M | $60.58M | (m) | $16.00K | (m) | (m) | 12 month · $281.00K |
| 2013-09-30 | $37.00K | $3.09M | $54.72M | $57.08M | (m) | $-769.00K | (m) | (m) | (m) |
| 2013-06-30 | $37.00K | $2.88M | $53.06M | $52.64M | (m) | $-3.34M | (m) | (m) | (m) |
| 2013-03-31 | $37.00K | $2.70M | $51.34M | $50.72M | (m) | (m) | (m) | $-3.37M | (m) |
| 2012-12-31 | $37.00K | $2.27M | $49.52M | $50.97M | (m) | $-851.00K | (m) | $-851.00K | 12 month · $178.00K |
| 2012-09-30 | $37.00K | $2.06M | $48.17M | $48.71M | (m) | (m) | (m) | $-1.55M | (m) |
| 2012-06-30 | $37.00K | $1.84M | $46.33M | $45.55M | (m) | (m) | (m) | $-2.66M | (m) |
| 2012-03-31 | $37.00K | $1.38M | $44.82M | $44.53M | (m) | (m) | (m) | $-1.70M | (m) |
| 2011-12-31 | $36.00K | $721.00K | $42.90M | $40.76M | (m) | (m) | (m) | $-2.91M | 12 month · $34.00K |
| 2011-09-30 | $36.00K | $651.00K | $41.92M | $40.37M | (m) | (m) | (m) | $-2.24M | (m) |
| 2011-06-30 | $36.00K | $554.00K | $40.54M | $40.00M | (m) | (m) | (m) | $-1.13M | (m) |
| 2010-12-31 | $36.00K | $107.00K | $38.92M | $37.79M | (m) | (m) | (m) | $-1.27M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |